GlassScriptPhysician profile
Christopher D Prihoda
NPI 1083620413
$6,304.56
in general payments reported to CMS, 2019-2025
50 companies · $1,258 in 2025
The $1,258 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $1,065 · 2021: $674 · 2022: $561 · 2023: $891 · 2024: $903 · 2025: $1,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,007 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,006.52 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,002.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $731.92 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $723.03 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $492.05 | 2019-2025 | |
| Abbvie INC. | $326.63 | 2020-2025 | |
| Abbott Laboratories | $233.01 | 2019-2024 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.60 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $204.02 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Renovia INC | $183.00 | 2020 | |
| Glaxosmithkline, LLC. | $149.46 | 2019-2023 | Shingrix, Bexsero |
| Exact Sciences Corporation | $146.24 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $144.03 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.69 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $108.21 | 2022 | |
| Amgen INC. | $103.34 | 2019-2025 | Repatha, Otezla |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Prihoda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.